GlassScriptPhysician profile
Michael Todd Cain
NPI 1366706129
$9,953.24
in general payments reported to CMS, 2019-2025
29 companies · $812 in 2025
The $812 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,648 · 2020: $435 · 2021: $2,005 · 2022: $1,731 · 2023: $1,781 · 2024: $540 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398 · Travel and Lodging: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.54 |
| Travel and Lodging | $735.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $2,054.19 | 2019-2021 | |
| Smith+Nephew, INC. | $1,500.95 | 2019-2025 | Aetos Shoulder System, Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Stryker Corporation | $1,356.16 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Flex Revive, Alphavent |
| Depuy Synthes Sales INC. | $988.78 | 2020-2025 | Healix Knotless Peek, Vapr, Dynacord |
| Zimmer Biomet Holdings, INC. | $918.24 | 2022-2023 | Saw Guide |
| Arthrex, INC. | $910.97 | 2023 | |
| Medacta USA, INC. | $512.07 | 2020-2023 | Primary Shoulder |
| Exactech, INC. | $496.09 | 2022 | |
| Shoulder Innovations, INC. | $298.67 | 2025 | Inset System |
| Abbott Laboratories | $262.32 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Spr Therapeutics, INC | $169.19 | 2024-2025 | Sprint Pns System |
| Vilex LLC | $81.56 | 2023 | |
| Baxter Healthcare | $57.09 | 2023 | Floseal |
| Paragon 28, INC. | $48.50 | 2019 | |
| Peerless Surgical INC. | $32.45 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $28.93 | 2025 | Xeomin |
| Averitas Pharma INC. | $28.27 | 2024 | Qutenza |
| Heraeus Medical, LLC. | $26.12 | 2023 | Palacos |
| Vericel Corporation | $19.73 | 2024 | Maci |
| Aroa Biosurgery Incorporated | $19.61 | 2023 | |
| Amgen INC. | $19.17 | 2025 | Krystexxa |
| Kerecis Limited | $18.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ipsen Biopharmaceuticals, INC | $18.70 | 2025 | Dysport |
| Horizon Therapeutics Plc | $18.63 | 2023 | Krystexxa |
| Ossur Americas, INC. | $17.21 | 2025 | |
| Ferring Pharmaceuticals INC. | $15.04 | 2022 | |
| Bioventus LLC | $14.14 | 2022 | |
| Pacira Therapeutics, INC. | $11.73 | 2020 | |
| Skeletal Dynamics INC | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.